Dilip Surana – CMD - Micro Labs Ltd. of Micro Labs
View Detailed Executive Profile →Professional Overview
- Dilip Surana serves as the Chairman and Managing Director of Micro Labs, a prominent Bangalore-based pharmaceutical company specializing in generics, particularly in the areas of cardiac diseases and diabetes.
- Under the leadership of Dilip Surana, Micro Labs has expanded its product portfolio to include a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs), contributing significantly to the healthcare sector.
- In 2019, Dilip Surana was honored with the 'Responsible Business Leader Award' at the Responsible Business Awards, recognizing his commitment to ethical business practices and corporate social responsibility.
- Dilip Surana has played a pivotal role in steering Micro Labs towards innovation, focusing on research and development to enhance the efficacy and accessibility of medications.
- As a leader, Dilip Surana has emphasized the importance of quality assurance and compliance within the pharmaceutical industry, ensuring that Micro Labs adheres to stringent regulatory standards.
- Under Dilip Surana's guidance, Micro Labs has established a robust distribution network, enabling the company to reach a wide array of markets both domestically and internationally.
- Dilip Surana has been instrumental in fostering a culture of continuous improvement and employee development within Micro Labs, contributing to a motivated workforce of approximately 3,778 staff members.
- In recent news, Dilip Surana made headlines for acquiring a luxurious residence in Bengaluru, reflecting his personal success and the financial growth of Micro Labs.
- Dilip Surana's strategic vision has led to significant investments in technology and infrastructure, positioning Micro Labs as a competitive player in the global pharmaceutical landscape.
- Through his leadership, Micro Labs has achieved numerous certifications and accolades, further solidifying its reputation as a trusted manufacturer in the pharmaceutical industry.
- Dilip Surana has actively participated in industry forums and discussions, advocating for advancements in healthcare policies and practices that benefit both patients and the pharmaceutical sector.
- His commitment to sustainability and responsible business practices has influenced Micro Labs' operational strategies, aligning them with global sustainability goals.
- Dilip Surana's entrepreneurial spirit and strategic foresight have been key drivers in the company's growth trajectory, enabling Micro Labs to adapt to changing market dynamics.
- Through philanthropic initiatives, Dilip Surana has contributed to community health programs, demonstrating a commitment to social responsibility beyond the corporate realm.
- As a prominent figure in the pharmaceutical industry, Dilip Surana continues to inspire future leaders through his dedication to innovation, quality, and ethical business practices.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Micro Labs Ltd. | M.D | Jan 2001 – Jan 2008 |
| ARIHANT FOUNDATIONS & HOUSING LIMITED | Director | 30-Dec-2005 – 05-May-2010 |
| MICRO NUTRACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| MICRO EROS PHARMACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 28-Jun-2010 – 23-Nov-2013 |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 17-Apr-2007 – 23-Nov-2013 |
| MICRO DERMACEUTICALS PRIVATE LIMITED | Director | 15-May-2009 – 12-Dec-2014 |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Additional Director | 10-Oct-2019 – 24-Dec-2020 |
| MICRO VET PRIVATE LIMITED | Director | 10-Dec-2013 – 12-Dec-2014 |
| MICRO OPTHALMIC PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| MICRO NOVA PHARMACEUTICAL PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| MICRO CARSYSON PRIVATE LIMITED | Director | 07-May-2009 – 12-Dec-2014 |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Additional Director | 06-Nov-2018 – 31-Aug-2019 |
| VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Additional Director | 04-Feb-2021 – 30-Sep-2021 |
| JAIN INTERNATIONAL TRADE ORGANISATION | Additional Director | 03-Apr-2007 – 11-Dec-2010 |
| Micro Labs Ltd. | CMD | Present |
| GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 31-Aug-2019 – Present |
| VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Director | 30-Sep-2021 – Present |
| ABCD TECHNOLOGIES LLP | Partner | 30-Nov-2023 – Present |
| MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 24-Dec-2020 – Present |
| JAIN INTERNATIONAL TRADE ORGANISATION | Director | 23-Mar-2023 – Present |
| BAHL AND COMPANY PRIVATE LIMITED | Director | 18-Sep-2015 – Present |
| MICRO LABS LIMITED | Managing Director | 18-Jul-1994 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| AAV-8269 | ABCD TECHNOLOGIES LLP | Partner | 30-Nov-2023 |
| U24232KA1973PLC002401 | MICRO LABS LIMITED | Managing Director | 18-Jul-1994 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 24-Dec-2020 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 31-Aug-2019 |
| U67190KA1946PTC160479 | BAHL AND COMPANY PRIVATE LIMITED | Director | 18-Sep-2015 |
| U72900KA2007PTC158284 | VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Director | 30-Sep-2021 |
| U74999MH2007NPL168975 | JAIN INTERNATIONAL TRADE ORGANISATION | Director | 23-Mar-2023 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| L70101TN1992PLC022299 | ARIHANT FOUNDATIONS & HOUSING LIMITED | Director | 30-Dec-2005 – 05-May-2010 |
| U24232KA2009PTC049781 | MICRO CARSYSON PRIVATE LIMITED | Director | 07-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049861 | MICRO DERMACEUTICALS PRIVATE LIMITED | Director | 15-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049993 | MICRO NUTRACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC049994 | MICRO EROS PHARMACEUTICALS PRIVATE LIMITED | Director | 29-May-2009 – 12-Dec-2014 |
| U24232KA2009PTC050065 | MICRO OPTHALMIC PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| U24232KA2009PTC050066 | MICRO NOVA PHARMACEUTICAL PRIVATE LIMITED | Director | 08-Jun-2009 – 12-Dec-2014 |
| U24301KA2013PTC072425 | MICRO VET PRIVATE LIMITED | Director | 10-Dec-2013 – 12-Dec-2014 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Additional Director | 10-Oct-2019 – 24-Dec-2020 |
| U45201KA2007PTC042509 | MICRO INFRASTRUCTURE INDIA PRIVATE LIMITED | Director | 17-Apr-2007 – 23-Nov-2013 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Additional Director | 06-Nov-2018 – 31-Aug-2019 |
| U65100KA2010PTC054250 | GCS INVESTMENTS AND FINANCIAL SERVICES PRIVATE LIMITED | Director | 28-Jun-2010 – 23-Nov-2013 |
| U72900KA2007PTC158284 | VNURTURE HEALTHCARE SOFTWARE SOLUTIONS PRIVATE LIMITED | Additional Director | 04-Feb-2021 – 30-Sep-2021 |
| U74999MH2007NPL168975 | JAIN INTERNATIONAL TRADE ORGANISATION | Additional Director | 03-Apr-2007 – 11-Dec-2010 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Micro Labs corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Dilip Surana's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Micro Labs's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)